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A 53-year-old female had a history of long-term hemodialysis. Periodic follow-up abdominal
ultrasonography revealed a tumor measuring 4 cm in diameter in an area adjacent to the upper pole of the
right kidney. Abdominal computed tomography and magnetic resonance imaging confirmed a right
adrenal tumor. Furthermore, adrenal scintigraphy after dexamethasone inhibition showed accumulation in
the right adrenal gland. An endocrinological test revealed that the plasma renin activity (PRA) was normal,
and that the plasma aldosterone (PAC) level was increased to 1,021.8 ng/dl. The PAC-to-PRA ratio (ARR)
was 5,109. Under a diagnosis of aldosterone-producing adrenal tumor, laparoscopic right adrenalectomy
was performed. After surgery, the PAC level was normalized. Pathological findings showed adrenal
cortical adenoma. Primary aldosteronism causes hypertension, hypopotassiumemia, hyporeninemia, and
hyperaldosteronemia via excessive secretion of aldosterone in the adrenal glands. However, the patient
showed a high serum level of potassium due to anuria, and hypertension was not noted. Thus, some dialysis
patients with primary aldosteronism do not show any typical clinical symptoms. A previous study also
indicated the presence of hyperaldosteronemia in patients with end-stage renal disease. A diagnosis should
be carefully made.
(Hinyokika Kiyo 56 : 21-24, 2010)




















接して 4 cm 径の腫瘤が指摘され，後天性嚢胞性腎疾
患 (acquired cystic disease of the kidney) に合併した腎
癌，あるいは副腎腫瘍が疑われ，2004年 1月，当科へ
紹介された．
現 症 : 身 長 157 cm，体 重 54 kg，血 圧 112/64







大径 4 cm の腫瘍を認め，副腎腫瘍を疑った．腹部
CT では右副腎に 4 cm の腫瘤を認め，辺縁および内
部の一部に軽度の造影効果を認めた (Fig. 1）．T1 造
影 MRI では，右副腎に内部に出血を疑う low intensity





た．また透析前の採血で Na は 138 mEq/l と正常で
あったがKは 5.5 mEq/l と高値であった．内分泌学
的検査は Table 1 に示したが安静臥床後の採血で血漿
レニン活性 (PRA) は 0.2 ng/ml/h と正常であった
が，血漿アルドステロン (PAC) は 1,021.8 ng/dl と








Fig. 1. Abdominal computed tomography showing
right adrenal mass measuring 4 cm, and
heterogeneously enhancement effects were
observed at the margin and in a portion of
the internal area.
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Fig. 2. Contrast-enhanced T1-weighted magnet
resonance imaging showing a low-intensity
right adrenal mass measuring 4 cm in
diameter, suggesting hemorrhage in the
internal mass, and the periphery was slightly
enhanced.
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Fig. 3. After dexamethasone at 2 mg/day was
administered for 7 days, 131I-adosterol
scintigraphy showing uptake into the right
adrenal mass (posterior to anterior view).
Table 1. Endocrinological examinations
PRA 0.2 ng/ml/h
PAC 1,021.8 ng/dl






Fig. 4. Gross appearance of tumor. The tumor
measured 3.5×3×2.5 cm in diameter.
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と診断された (Fig. 5）．術後 1 カ月目に行った採血
で，PRA は 0.2 ng/ml/h と術前と変化なかったが
PAC は 5.4 ng/dl と正常化していた．血清カリウム値
















































































Fig. 5. Histologic examination revealed portion of
the tumor cells with lightly eosinophilic
cytoplasm, and consisted of lipid-rich cells.
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